| |
| |
|
| Insider
Information: |
Cogan John Francis |
| Relationship: |
Director |
| City: |
San Jose |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,533 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,525,852 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,533 |
|
|
| Total
Value |
$3,525,852 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Monaco Coach Corp |
MCOAQ |
Director |
2009-01-05 |
6,673 |
2006-04-03 |
0 |
Premium* |
|
|
Gilead Sciences Inc |
GILD |
Director |
2020-05-04 |
54,860 |
2010-05-06 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
110 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-05-04 |
4 |
OE |
$26.62 |
$155,325 |
D/D |
5,836 |
58,455 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-05-04 |
4 |
AS |
$65.09 |
$379,885 |
D/D |
(5,836) |
52,619 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2018-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,241 |
54,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-03-20 |
4 |
OE |
$22.02 |
$59,441 |
D/D |
2,700 |
57,560 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-03-20 |
4 |
AS |
$65.07 |
$175,689 |
D/D |
(2,700) |
54,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-03-27 |
4 |
AS |
$64.14 |
$173,178 |
D/D |
(2,700) |
54,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-03-27 |
4 |
OE |
$22.02 |
$59,441 |
D/D |
2,700 |
57,560 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-03 |
4 |
OE |
$22.02 |
$59,441 |
D/D |
2,700 |
57,560 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-03 |
4 |
AS |
$66.74 |
$180,198 |
D/D |
(2,700) |
54,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-10 |
4 |
OE |
$22.02 |
$59,441 |
D/D |
2,700 |
57,560 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-10 |
4 |
AS |
$67.23 |
$181,521 |
D/D |
(2,700) |
54,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-17 |
4 |
OE |
$22.02 |
$59,441 |
D/D |
2,700 |
57,560 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-17 |
4 |
AS |
$64.21 |
$173,424 |
D/D |
(2,700) |
54,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-24 |
4 |
AS |
$62.61 |
$169,054 |
D/D |
(2,700) |
54,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-04-24 |
4 |
OE |
$22.02 |
$59,441 |
D/D |
2,700 |
57,560 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-05-01 |
4 |
OE |
$22.02 |
$63,139 |
D/D |
2,868 |
57,728 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2019-05-01 |
4 |
AS |
$64.89 |
$186,116 |
D/D |
(2,868) |
54,860 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-03-09 |
4 |
OE |
$19.63 |
$47,367 |
D/D |
2,413 |
57,273 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-03-09 |
4 |
AS |
$77.97 |
$188,142 |
D/D |
(2,413) |
54,860 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-03-16 |
4 |
AS |
$67.26 |
$162,298 |
D/D |
(2,413) |
54,860 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-03-16 |
4 |
OE |
$19.63 |
$47,367 |
D/D |
2,413 |
57,273 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-03-23 |
4 |
OE |
$19.63 |
$47,367 |
D/D |
2,413 |
57,273 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-03-23 |
4 |
AS |
$75.27 |
$181,627 |
D/D |
(2,413) |
54,860 |
0 |
% |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-03-30 |
4 |
OE |
$19.63 |
$47,367 |
D/D |
2,413 |
57,273 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Director |
• • – |
2020-03-30 |
4 |
AS |
$75.35 |
$181,820 |
D/D |
(2,413) |
54,860 |
0 |
% |
|
110 Records found
|
|
Page 4 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
